Kina Höglund

Overview

Best Publications

• Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

  Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  1260
  Citations

• Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

  Bob Olsson;Bob Olsson;Erik Portelius;Erik Portelius;Nicholas C. Cullen;Nicholas C. Cullen;Åsa Sandelius

  250
  Citations

• Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

  Erik Portelius;Erik Portelius;Bob Olsson;Bob Olsson;Kina Höglund;Kina Höglund;Nicholas C. Cullen

  191
  Citations

• Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.

  Erika Bereczki;Paul T. Francis;David R. Howlett;Joana B. Pereira

  186
  Citations

• Marked increase of β-amyloid (1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury

  Annika Olsson;Ludvig Csajbok;Martin Öst;Kina Höglund

  185
  Citations

• Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

  Nicholas J. Ashton;Antoine Leuzy;Yau Mun Lim;Yau Mun Lim;Claire Troakes;Claire Troakes

  185
  Citations

• Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.

  Annika Olsson;Kina Höglund;Magnus Sjögren;Niels Andreasen

  183
  Citations

• A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

  Lorenzo Gaetani;Kina Höglund;Kina Höglund;Lucilla Parnetti;Fani Pujol-Calderon

  178
  Citations

• An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

  Nicholas J. Ashton;Abdul Hye;Abdul Hye;Anto P. Rajkumar;Anto P. Rajkumar;Anto P. Rajkumar;Antoine Leuzy

  172
  Citations

• Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.

  Claudia Cicognola;Gunnar Brinkmalm;Jessica Wahlgren;Erik Portelius;Erik Portelius

  166
  Citations

• Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia

  Bob Olsson;Joakim Hertze;Ronald Lautner;Henrik Zetterberg

  146
  Citations

• Plasma Levels of β-Amyloid(1-40), β-Amyloid(1-42), and Total β-Amyloid Remain Unaffected in Adult Patients With Hypercholesterolemia After Treatment With Statins

  Kina Höglund;Olov Wiklund;Hugo Vanderstichele;Oliver Eikenberg

  132
  Citations

• Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.

  Silke Kern;Henrik Zetterberg;Jürgen Kern;Anna Zettergren

  127
  Citations

• Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.

  Pashtun Shahim;Yelverton Tegner;Bengt Gustafsson;Magnus Gren

  117
  Citations

• The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

  K. Höglund;K.M. Thelen;S. Syversen;M. Sjögren

  116
  Citations

• Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology

  Kaj Blennow;Kaj Blennow;Chun Chen;Claudia Cicognola;Kristin R Wildsmith

  100
  Citations

• Characterization of Tau in Cerebrospinal Fluid Using Mass Spectrometry

  Erik Portelius;Sara F. Hansson;Ai Jun Tran;Henrik Zetterberg

  94
  Citations

• Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.

  Kina Höglund;Kaj Blennow

  89
  Citations

• Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer disease.

  Marion Tible;Åsa Sandelius;Åsa Sandelius;Kina Höglund;Kina Höglund;Ann Brinkmalm;Ann Brinkmalm

  84
  Citations

• Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.

  K Höglund;S Kern;S Kern;A Zettergren;A Zettergren;A Börjesson-Hansson;A Börjesson-Hansson

  76
  Citations

• The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease

  Hlin Kvartsberg;Tammaryn Lashley;Christina E. Murray;Gunnar Brinkmalm

  74
  Citations

• Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

  Thomas K. Karikari;Augustina Charway-Felli;Kina Höglund;Kaj Blennow;Kaj Blennow

  38
  Citations